Anti-Gal-C antibodies in GBS subsequent to mycoplasma infection: Evidence of molecular mimicry

Neurology

Volumn 57, Issue 4, 2001, Pages 736-738

  Kusunoki, Susumu ^a   Shiina, Meiko ^a   Kanazawa, Ichiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; GALACTOSYLCERAMIDE;

ANTIGEN RECOGNITION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAM NEGATIVE INFECTION; GUILLAIN BARRE SYNDROME; HUMAN; MOLECULAR MIMICRY; MYCOPLASMA PNEUMONIAE; PRIORITY JOURNAL; THIN LAYER CHROMATOGRAPHY;

EID: 0035964152     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.57.4.736     Document Type: Article

References (10)

1. Experimental allergic neuritis induced by sensitization with galactocerebroside
2. Anti-Gal-C antibody in autoimmune neuropathies subsequent to mycoplasma infection
3. Post-infectious encephalitis with anti-galactocerebroside antibody subsequent to Mycoplasma pneumoniae infection
4. Encephalomyelitis subsequent to mycoplasma infection with elevated serum anti- Gal C antibody
5. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure
6. Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain-Barré syndrome: Evidence of molecular mimicry
7. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome
8. Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacterjejuni isolated from patients with Fisher's syndrome
9. Serum anti-GQ1b IgG antibodies recognize surface epitopes on Campylobacter jejuni from patients with Miller Fisher syndrome
10. Association of anti-GM2 antibodies in Guillain-Barré syndrome with acute cytomegalovirus infection